The sme-instrument: 3,6 million euro to symcel

In good cooperation with SymCel, GAEU Consulting first wrote a Phase 1 application within the Horizon 2020 SME-Instrument that got approved and then wrote the Phase 2 application that granted the company 3,6 million for clinical validation of customized antimicrobial susceptibility testing.

 

– Thank you to all involved in SymCel and GAEUs production teams!

http://symcel.se/2017/11/21/symcel-secures-e3-6-million-for-antibiotic-susceptibility-testing/